3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
6
fludarabine
4
Magnetic Resonance Spectroscopy
3
Flow Cytometry
3
trametinib
2
pembrolizumab
2
liposomal doxorubicin
2
dabrafenib
2
aldesleukin
2
Specimen Handling
2
Methylprednisolone
2
Immunologic Techniques
2
Gemcitabine
2
Dexamethasone
2
Biopsy
2
Azacitidine
2
Alemtuzumab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
sargramostim
1
saracatinib
1
sapanisertib
1
ruxolitinib
1
rucaparib
1
resiquimod
1
relatlimab
1
poly ICLC
1
pertuzumab
1
palbociclib
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Molecular Diagnostic Techniques
×
Plasma cell
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled